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ASSOCIATION OF HORMONAL
CONTRACEPTION WITH DEPRESSION
Pamela Derickson, MS-III
Community Health Improvement Project
The Community Health Centers of Burlington
Rotation 4, 2018

SLIDE 2: PROBLEM IDENTIFICATION
• Hormonal oral contraceptives (OCPs) are widely used by women during their
reproductive years
• OCP use, especially among adolescents, is associated with subsequent use of
antidepressants and a first diagnosis of depression, suggesting depression may be a
potential adverse effect of hormonal contraceptive use1
Description of need:
• Health care providers should be aware of newer literature showing the effect of
hormonal contraceptive on mood so they can address mood changes and intervene
appropriately

SLIDE 3: PUBLIC HEALTH COSTS OF DEPRESSION
AND OCP USE
Hormonal oral contraceptives (OCPs) are widely used by women during their reproductive years:
• 17% of women in the US ages 15-44 currently use OCPs2
• 11.6 million American women use oral contraceptive pills as their primary contraceptive method3
• 82% of sexually active women in the USA will use OCPs at some time during their reproductive years4
Annually in the US:
• Office visits for contraception management total $100 million in medical costs (CDC, 2012)5
• Depression affects up to 9 percent of patients and accounts for more than $43 billion in medical care
costs6
• Because of the association between OCP use and depression, many of these costs are overlapping

SLIDE 4: COMMUNITY PERSPECTIVE ON ISSUE
Interviewed multiple providers following the educational presentation:
• OCPs are not the most commonly prescribed birth control method at CHCB, compared to intrauterine
systems and Nexplanon implants
• Multiple providers have previously observed that intrauterine systems and Nexplanon implants are removed
more frequently than inserted, but this observation was not assessed to be related to mood or depression
• Current practices at CHCB do not include screening women on OCPs for depression beyond the
recommendation by USPSTF for all adults to be screened for depression using the PHQ-2, and if that is
positive, to then administer the PHQ-9
• Additional research was discussed by another provider about the incidence of OCP use and suicidality and
suicide completion7

SLIDE 5: INTERVENTION AND METHODOLOGY
Intervention:
• This project focused on educating health care providers at the Community Health Center of Burlington, VT
(CHCB) about the association of depression and oral contraceptives
• Providers then had an open discussion regarding prescribing habits at CHCB for OCPs and current followup procedures with patients after starting OCPs

Methodology:
• Reviewed literature on the incidence of OCPs and their association with depression, mood, suicidality, and
neuroanatomic changes and present research to providers at CHCB

SLIDE 6: RESULTS

SLIDE 7A: EVALUATION OF EFFECTIVENESS
• Information was provided through an in-person presentation to providers and circulated via
email to all providers at CHCB, ensuring all providers had access to the presentation
• A survey will be distributed to assess effectiveness of the presentation to providers at CHCB
• The survey includes any change in prescribing practices, so it will be issued in a one-month
interval
• The survey also includes any change in follow-up screening for depression in women on OCPs

SLIDE 7B: EVALUATION OF LIMITATIONS
• Not all providers at CHCB could attend the presentation, and the information distributed in an
email may not be as effective as an in-person presentation
• The literature provided was for clinicians at CHCB, and not for patients. This may dilute the
amount of information provided to patients regarding symptoms of depression with OCP use
• Physician apprehension to change their current practices of prescribing OCPs due to their ability
to prevent unwanted pregnancy, ease of use, and relative cost-effectiveness

SLIDE 8: RECOMMENDATIONS FOR FUTURE
INTERVENTIONS
• More studies with more robust study designs to further correlate relationships between OCPs,
mood, depression, suicidality and neuroanatomic changes especially in our community
• Future research will focus on women’s PHQ-9 and GAD-7 (two validated scoring systems to
quantify symptoms of depression and anxiety, respectively) before starting OCPs and at 3month, 6-month, and 1-month follow up appointments pending IRB approval
• Age-matched women not on OCPs will be used as controls with PHQ-9 and GAD-7 scores
recorded at 3-month, 6-month, and 1-month follow up appointments
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